Clinical trial
A Randomized, Placebo-controlled, Double-blind Clinical Study to Evaluate the Effect of Humiome® Post LB on Stress, Anxiety, and Cognition in Aging Adults
NCT07110896 is registered in ClinicalTrials.gov with dsm-firmenich Switzerland AG as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Placebo-controlled, Double-blind Clinical Study to Evaluate the Effect of Humiome® Post LB on Stress, Anxiety, and Cognition in Aging Adults
- Lead sponsor
- dsm-firmenich Switzerland AG
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- August 1, 2025
- Completion date
- November 30, 2026
- Enrollment
- 236 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
healthy aging